Login to Your Account



Pharma: Clinic Roundup


Friday, June 22, 2012
• Iroko Pharmaceuticals LLC, of Philadelphia, reported Phase III study results that showed patients treated with its submicron particle, lower-dose diclofenac experienced significant pain relief following surgery compared with placebo.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription